Volato Group, Inc. (the "Company" or "Volato") , today announced preliminary financial guidance for the fourth quarter and full year ending December 31, 2025, reflecting continued execution against ...

Guselkumab has received approval for moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy.1The decision is supported by the ...

Oil and Gas Veterans to Serve on Board to Drive Value CreationFiled Amended Form S-4 to Include EQV Resources Acquisition, Board Appointments ...

VANCOUVER, BC / ACCESS Newswire / December 5, 2025 / Northern Dynasty Minerals Ltd. (TSX:NDM)(NYSE American:NAK) ("Northern Dynasty" or the "Company") is pleased to provide an update on the process ...

An approximately $24,000 net increase in monthly subscription sales to date since November 2025Localizer adoption expands to 145 independent ...

ECD Automotive Design, Inc. ("ECD" or the "Company") , the world's largest Land Rover and Jaguar restoration company known for its custom luxury builds, including bespoke Defenders, Range Rovers, ...

Qualstar Corporation (OTC: QBAK), a leading manufacturer of data storage solutions and high-efficiency power supplies, announced a partnership with Scale Logic to create integrated solutions that ...

Revenue increased 23% year-over-year ARR up 23% year-over-year MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--SentinelOne, Inc. (NYSE: S) today announced financial results for the third quarter of fiscal ...

We wrapped up our annual Conference on Current SEC and PCAOB Developments last week, and it’s hard to pick a single theme or ...

MIAMI BEACH, FLORIDA / ACCESS Newswire / December 18, 2025 / LQR House Inc. (the “Company” or “LQR House”) (NASDAQ:YHC), a niche ecommerce platform specializing in the spirits and beverage industry, ...

TWO (Two Harbors Investment Corp, NYSE: TWO), an MSR-focused REIT, today declared a dividend of $0.34 per share of common ...

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced that it has entered into ...